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Background: In many countries, in-hospital survival from tetanus is increasing, but long-term outcome is
unknown. In high-income settings, critical illness is associated with muscle wasting and poor functional out-
come, but there are few data from resource-limited settings. In this study we aimed to assess muscle wasting
and long-term functional outcome in adults with tetanus.
Methods: In a prospective observational study involving 80 adults with tetanus, sequential rectus femoris
ultrasound measurements were made at admission, 7 days, 14 days and hospital discharge. Functional out-
come was assessed at hospital discharge using the Timed Up and Go test, Clinical Frailty Score, Barthel Index
and RAND 36-item Short Form Health Survey (SF-36) and 3 and 6 months after discharge using the SF-36 and
Barthel Index.
Results: Significant muscle wasting occurred between hospital admission and discharge (p<0.01), particularly
in severe disease, where a median 23.49% (interquartile range 10.01–26.07) reduction in rectus femoris
cross-sectional area occurred in those with severe (Ablett grades 3 and 4) disease. Muscle mass at discharge
was related to objective and subjective measures of physical and emotional function at discharge and 3 and
6 months after discharge. In patients >70 y of age, functional recovery at 6 months was reduced compared
with younger patients. Hospital-acquired infection and age were risk factors for muscle wasting.
Conclusions: Significant muscle wasting during hospitalization occurred in patients with tetanus, the extent of
which correlates with functional outcome.
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Tetanus remains a significant problem in many low- and
middle-income countries (LMICs), responsible for up to 50 000
deaths annually.1 However, even in resource-limited settings,
with good care, survivorship from tetanus is often >90%.2–4 The
functional outcome of these survivors is unknown and while
there are limited data regarding neurodevelopmental outcome
following neonatal tetanus, there are no studies of long-term
outcome in adults.5 In many countries, as a result of successful
childhood and maternal vaccination programs, tetanus predom-
inantly affects working-age men,1 thus the consequence of lim-
ited functional recovery may have far-reaching social and
economic impact.
In high-income countries, intensive care unit (ICU) survivorship
is frequently associated with significant disability.6 ICU-acquired
weakness and muscle wasting are potentially modifiable contribu-
tors to this, both in the short term (length of stay, mortality, length
of mechanical ventilation) and long term (mortality, continued
functional decline, discharge to a rehabilitation centre).7–10 Bed
rest, duration of mechanical ventilation, inflammatory response,
corticosteroids and glycaemia have all been implicated in muscle
wasting and weakness, although the role of other factors, such as
neuromuscular blocking agents, remains unclear.11–13 The intro-
duction of point-of-care ultrasonography means that quantifica-
tion of muscle wasting in low-resource settings is now feasible.
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Ultrasound measurement of quadriceps femoris has been shown
to be a reliable method for measuring muscle mass. It can be per-
formed in sedated or unconscious patients and has good inter-
and intra-observer reliability.10 The cross-sectional area of the
quadriceps has been shown to correlate with functional outcome
and a linear relationship between ultrasound measurement of rec-
tus femoris cross-sectional area (RF-CSA) and quadriceps strength
has been demonstrated.9,10
Patients with tetanus may be particularly at risk of muscle
wasting and poor outcome due to long periods in the ICU and
prolonged use of mechanical ventilation and muscle relaxants.3
In this study we aimed to characterize functional outcome and
changes in muscle quantity in a large cohort of patients with
tetanus. Much previous work on muscle wasting has been con-
founded by population heterogeneity. By recruiting only those
with tetanus in this study, we were able to examine muscle
wasting in a single, clearly defined disease and a population
with low comorbidity or other factors likely to introduce bias.
Methods
This was a prospective observational study, approved by the
Scientific and Ethics Committee of the Hospital for Tropical
Diseases and the Oxford Tropical Research Ethics Committee
(OxTREC). All subjects, or their representatives, gave written
informed consent prior to enrolment according to Vietnamese
Ministry of Health policy and good clinical practice guidelines.
Patients were enrolled in the adult ICU at the Hospital for
Tropical Diseases, Ho Chi Minh City between August 2016 and
March 2017. The hospital is an 850-bed tertiary referral centre
for infectious diseases, serving southern Vietnam (population 44
million). Its adult ICU is a 20-bed medical ICU with facilities for
mechanical ventilation and haemofiltration. Tetanus manage-
ment in our ICU follows a standard management protocol.
Muscle spasms are controlled with benzodiazepines, with mag-
nesium sulphate and neuromuscular blocking agents as
second-line agents following tracheostomy. Autonomic nervous
system dysfunction is treated with magnesium sulphate.
Steroids are not used in treatment. All patients received intra-
muscular equine antitoxin and metronidazole.
Adult patients ≥16 y of age with a clinical diagnosis of gener-
alized tetanus and within 48 h of ICU admission were eligible
for study entry. Tetanus was diagnosed according to clinical cri-
teria detailed in the Hospital for Tropical Diseases Guidelines
Volume 6, including generalized muscle rigidity and/or muscle
spasm, without alteration in consciousness or fever at the onset
of symptoms.14 Those failing to give informed consent, unable
to walk unaided prior to hospitalization or with contraindication
to ultrasound were excluded. A sample size of 80 patients was
estimated to detect a 15% reduction of RF-CSA between hos-
pital admission and discharge with 95% confidence and 5%
error. For logistical reasons, patients admitted on weekends or
during shifts when study staff were not available were not
enrolled.
Baseline clinical and demographic data were recorded and
daily clinical assessments of patients were performed through-
out the ICU stay. The duration of mechanical ventilation, dose
and duration of muscle relaxant drugs and hospital-acquired
infection events were recorded. Both midazolam and diazepam
were used and doses recorded. Generally, practice in our unit is
to give midazolam to more severe patients; however, issues
such as cost and availability may also influence benzodiazepine
prescription. Tetanus severity stage was classified using the
modified Ablett grades,15,16 where mild tetanus was defined as
Ablett grades 1 and 2 and severe tetanus as grades 3 and 4.
The Ablett grade may change during hospitalization and is
intrinsically linked to events such as mechanical ventilation, sed-
ation and hospital-acquired infection, therefore the baseline
Tetanus Severity Score was used in risk factor analyses.15,16
Muscle mass was determined using B-mode ultrasound
measurement of RF-CSA using an M-Turbo ultrasound machine
with a standard 5–2 MHz C60Xi transducer (FUJIFILM SonoSite,
Bothell, WA, USA). Measurements were performed according to
a standard operating procedure previously described.10 Briefly,
patients were laid in a supine position with legs in a neutral
rotation and passive extension. Measurements were taken from
the right leg at the midpoint between the anterior superior iliac
spine and patella upper pole. This position was marked for sub-
sequent assessments. The transducer was placed perpendicular
to the skin and in a transverse position (perpendicular to the
thigh’s long axis). An excess of ultrasound gel was placed on the
skin to prevent skin depression by the transducer. Ultrasound
measurements were taken at baseline, 7 and 14 d and at hos-
pital discharge. For each time point, measurements were taken
in triplicate and the average was calculated and used for ana-
lyses. Measurements were carried out by three operators.
Operators were deemed competent to perform study measure-
ments if intra- and interobserver variation of <5% was attained
from a test series of 30 images.
At hospital discharge, functional outcome was assessed
using objective and subjective measures: RAND 36-item Short
Form Health Survey (SF-36), Barthel Index, Timed Up and Go
test and Clinical Frailty Score.17–20 The SF-36 has previously
been translated and used in Vietnamese subjects, but there are
no normative data in this population.21 At 3 and 6 months fol-
lowing hospital discharge, Barthel Index and SF-36 question-
naires were performed by telephone.
All data were recorded in standard case record forms and
transferred to a secure database. Statistical analysis was per-
formed with R software (Version 3.5.1, R Foundation for Statistical
Computing, Vienna, Austria). Data are presented as median (inter-
quartile range [IQR]). Baseline and clinical characteristics were
compared using Mann–Whitney U and χ2 tests. Median muscle
mass and age-related functional outcome scores were compared
using the Mann–Whitney U test and multiple comparisons of
these adjusted using the Bonferroni correction. All longitudinal
measurements of muscle mass at baseline, 7 and 14 d and hos-
pital discharge were included in the analysis. The association
between functional outcome and muscle mass was analysed
using a linear regression model. For reliability of the SF-36,
Cronbach’s α was calculated for each domain score using ‘psy’ in
the R package.
To investigate the effect of hospital-acquired infection, venti-
lation, neuromuscular blocking agents and magnesium sulphate
on muscle wasting, a linear mixed effects model was used. This
model can incorporate multiple repeated measurements at
varying time points, eliminate effects of between-subject
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variability and incorporate non-independent and time-
dependent covariates. RF-CSA was the outcome variable, mod-
elled with time from ICU admission and hospital-acquired infec-
tion as time-dependent covariates and mechanical ventilation,
neuromuscular blocking agents and magnesium sulphate as
time-independent covariates. The relationship between time
since admission to the ICU and RF-CSA was modelled a flexible
way using restricted cubic splines with three knots [7,14,21]. A
random patient-specific intercept and slope was included to
account for individual heterogeneity. The model was adjusted
for potential confounding covariates of age, comorbidity and
tetanus severity using the Tetanus Severity Score, a baseline
score constructed from clinical features on admission.16,22
Results
A total of 80 patients were recruited to the study between
August 2016 and March 2017 (Supplementary Figure 1). All
patients had ultrasound assessments 7 days after enrolment
but two patients with mild disease were discharged from the
hospital before day 14 scans (these patients had a discharge
scan but no day 14 scan). One patient was transferred to
another hospital after 15 d and subsequently died in that hos-
pital, leaving 79 patients with complete assessments at hospital
discharge. One patient, reported to have recovered completely
at 3 months, died suddenly before the 6-month follow-up, fol-
lowing a short febrile illness. Seven patients were lost to follow-
up with 75 patients completing functional outcome assessments
at 3 months and 71 at 6 months.
Muscle mass
Summary baseline data for subjects are given in Table 1.
Overall, compared with baseline, RF-CSA was reduced by a
median 6.63% (IQR 2.73–13.73) at day 7, 11.94 % (IQR
5.41–21.1) at day 14 and 12.3% (IQR 4.7–23.57) at discharge.
The linear mixed effects model showed a significant reduction
in muscle mass between admission and discharge (p<0.01;
Table 2, Supplementary Figure 2). Muscle wasting was greatest
in patients with severe disease (Ablett grades 3 and 4)
(Figure 1). Seven days after hospitalization, patients with mild
disease (Ablett grades 1 and 2) had lost a median 4.57% (IQR
1.81–10.20) RF-CSA compared with those with Ablett grades 3
and 4 (9.01% [IQR 3.95–16.85]) (n=80, p=0.15). At day 14, the
median reduction was 7.12% (IQR 3.11 −17.5) in those with
mild disease compared with 16.54% (IQR 13.23−24.10) for
those with Ablett grades 3 and 4 (n=78, p<0.01), and at hos-
pital discharge there was a median 8.86% (IQR 2.9–16.54)
decrease in patients with mild disease compared with 23.49%
(IQR 10.01–26.07) with Ablett grades 3 and 4 (n=80, p=0.03).
Thirty-nine patients with mild tetanus and four patients with
severe tetanus were discharged from the ICU within 3 d of a
day 7 or day 14 rectus femoris ultrasound measurement. At ICU
discharge, these patients had lost a median 9.07% (IQR
3.27–17.32) of RF-CSA compared with baseline. By hospital dis-
charge, no recovery of RF-CSA occurred, with area a median
9.91% (IQR 3.93–15.01) less than baseline (p=0.77). The median
time between ICU discharge and hospital discharge ultrasound
measurements was 12 d (IQR 9.5–16).
Risk factors for muscle wasting
Using the linear mixed effects model, accounting for baseline
severity and time since ICU admission, hospital-acquired infec-
tion and age were identified as independent risk factors for
muscle wasting (Table 2; p<0.01 for both) but not the use of
non-depolarizing neuromuscular blocking agents. A total of 29
patients developed hospital-acquired infections during the
study: 12 with ventilator-associated pneumonia, 13 with urinary
tract infection, 12 with bloodstream infection and 13 with
‘other’ infections (8 patients were treated for two or more infec-
tions). The majority of infections were treated with carbapenem
antibiotics (20 patients), vancomycin (8 patients), fluroquino-
lones (9 patients) or third-generation cephalosporins (3
patients).
Functional outcomes
Functional outcome measures are shown in Table 3. The SF-36
Cronbach’s α showed good reliability, as shown in
Supplementary Table 1. Both the Barthel Index and SF-36
domain scores improved by 3 and 6 months compared with dis-
charge (Table 3). While overall scores improved by 3 and 6
months, in the subgroup of patients ≥70 y of age, functional
recovery was significantly less than in younger individuals. At 3
and 6 months, all SF-36 domain scores were lower in patients
≥70 y of age than in younger patients (p≤0.05 for all; Figure 2).
Similarly Barthel Index scores were lower in older patients
(median 80 [IQR 74–85] vs 10 [IQR 100–100] at 3 months;
median 80 [IQR 80–96] vs 100 [IQR 100–100] at 6 months;
p<0.01 for both).
The relationship between functional outcomes and muscle
wasting is shown in Supplementary Tables 2 and 3. Lower RF-
CSA at hospital discharge was associated with worse functional
outcome scores at hospital discharge as well as 3 and 6 months
after discharge. Specifically, at hospital discharge, lower RF-CSA
was associated with a statistically significant slower Timed Up
and Go, increased Clinical Frailty score, lower Barthel Index and
lower SF-36 physical functioning domain scores. A statistically
significant association remained between RF-CSA measure-
ments at hospital discharge and Barthel Index scores 6 months
after discharge. RF-CSA measurements at hospital discharge
were also statistically significantly associated with lower SF-36
scores in all domains except emotional wellness 6 months after
discharge.
Discussion
We investigated muscle mass loss and subsequent functional
impairment in patients suffering from tetanus in a resource-
limited setting. Mortality in our cohort was low, consistent with
previously reported mortality at our centre. We attribute this
largely to the expertise of a specialized centre, young age and
limited comorbidity of the subjects. Nevertheless, in this study
we found notable functional impairment at hospital discharge
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in survivors, with significant muscle loss during hospitalization,
the extent of which was related to disease severity, age and the
acquisition of hospital-acquired infection. Muscle mass at dis-
charge was related to both objective and subjective measures
of physical function.
Patient heterogeneity has been identified as one of the diffi-
culties in understanding muscle wasting.23 Data from our study
are derived from patients with a homogeneous non-
inflammatory pathology, limited comorbidities, a common
treatment protocol and within a narrow age range. Although we
did not include a control group of other critically ill patients
from our setting, our cohort demonstrated similar magnitudes
and rates of reduction in RF-CSA to those described in mixed
Western ICU populations and greater than those observed in
healthy immobilized subjects.10,24,25 Our additional data with
14- and 21-d measurements demonstrates ongoing muscle
mass loss into the second and third week of ICU stay.
Despite the nature of our study setting, we were able to con-
tact the majority of patients after discharge, gaining insight into
long-term outcomes following tetanus and the role of muscle
mass. Low muscle mass at discharge was associated with
poorer physical outcomes using objective (Timed Up and Go
test, Barthel Index) and subjective (SF-36) measures. Further,
low muscle mass at discharge was associated with increased
frailty. While increased frailty has been noted in young critical
care survivors, identification of the relationship with muscle
mass has not occurred previously.26
Encouragingly in our cohort, most patients reported good
recovery by 6 months, much of which occurred by 3 months. In
healthy populations, spontaneous recovery of muscle cross-
sectional area has been shown to occur rapidly following cessa-
tion of immobilization, but we found no evidence of recovery of
RF-CSA between ICU and hospital discharge.27 While the rea-
sons for our finding are unclear, suboptimal nutrition and lack of
Table 1. Patient characteristics
Characteristics All patients (n=80) Ablett grades 1 and 2
(n=48)
Ablett grades 3 and 4
(n=32)
p-
Value
Baseline
Age (years), median (IQR) 49 (35–59.5) 46 (33.5–57) 51.5 (41.5–64.5) 0.15
Male:female ratio, n:n 64:16 9:39 7:25 0.73
Tetanus Severity Score, median (IQR) −1 (−6–2) −2 (−5–0) 1 (−2.25–5.25) <0.01
SOFA score, median (IQR) 0 (0–0) 0 (0–0) 0 (0–0) 0.15
SOFA >0, n (%) 7 (9) 2 (4) 5 (16) 0.15
Subjects with comorbidity, n (%) 22 (27.5) 11 (22.9) 11 (34.4) 0.26
Subjects with hospital-acquired infection, n (%) 28 (35) 6 (12.5) 22 (69) <0.01
Diabetes, n (%) 8/80 (10) 5 (3) 3 (9.7) 0.92
Hypertension, n (%) 18/80 10 (0.21) 8 (25) 0.66
Previous myocardial infarction, n (%) 1/80 (1.3) 0 (0) 1 (3.1) 0.83
Congestive heart failure, n (%) 0 (0) 0 (0) 0 (0) 1
Peripheral vascular disease, n (%) 1 (1.3) 0 (0) 1 (3.1) 0.83
Cerebrovascular disease, n (%) 1 (1.3) 1 (2.1) 0 (0) 1
Chronic obstructive pulmonary disease, n (%) 0 (0) 0 (0) 0 (0) 1
Chronic liver disease, n (%) 1 (1.3) 1 (2.1) 0 (0) 1
Charlson Comorbidity Index, median (IQR) 0 (0–1) 0 (0–0) 0 (0–1) 0.32
Clinical features
Hospital length of stay (days), median (IQR) 25 (20–33) 21 (18–25) 34 (30–42.5) <0.01
ICU length of stay (days), median (IQR) 14 (7–23) 8 (5–12) 25 (20–30) <0.01
Body mass index, median (IQR) 20.95 (19.14–23.70) 21.16 (19.13–24.07) 20.81 (19.51–23.46) 0.71
Total diazepam (mg), median (IQR) 437.5 (211.3–955) 565 (293.8–858.8) 235 (126.25–2362.5) <0.01
Total midazolam (mg), median (IQR) 220 (0–1771) 0 (0–539) 1602.5 (0–2603) <0.01
Total pipecuronium (mg), median (IQR) 224.4 (0–542.4) 0 (0–0) 493 (312–604) <0.01
Total magnesium (g), median (IQR) 0 (0–0) 0(0–0) 24 (0–252) <0.01
Mechanical ventilation, n (%) 32 (40) 2 (42) 30 (94) <0.01
Duration of mechanical ventilation (days), median
(IQR)
0 (0–15) 0 (0–0) 16.5 (13–23) <0.01
Renal replacement therapy, n (%) 0 (0) 0 (0) 0 (0) 1
In-hospital deaths, n (%) 0 (0) 0 (0) 0 (0) 1
180-d deaths, n (%) 2 (2.5) 0 (0) 2 (6.2) 0.08
Lost to follow-up at 3 months, n (%) 3 (3.8) 3 (6.25) 0 (0) 0.15
Lost to follow-up at 6 months, n (%) 7 (8.8) 5 (10.4) 2 (6.3) 0.52
Transactions of the Royal Society of Tropical Medicine and Hygiene
709
rehabilitation may be important factors, warranting further
investigation.
Despite our cohort being younger than others studied, age
was noted as a risk factor for increased muscle wasting.10,22
Comorbidities were not noted to be a risk factor, and these were
of low frequency and mild relative to Western populations. In
other ICU populations, rates of muscle wasting and weakness
are associated with the degree of multi-organ failure.22,28 This
was not seen in our population, likely as a result of the lack of
organ failure. There was a relationship between disease severity,
indicated by the Ablett grade, and increased wasting. However,
Ablett grade changes with time and is defined by respiratory
and autonomic complications, and thus is also linked to possible
risk factors. In risk factor analysis, using a validated baseline dis-
ease severity score (Tetanus Severity Score), no relationship
between severity and wasting was seen.16 It is therefore likely
that the increased muscle wasting shown by the Ablett grade
was related to differences in treatment or complications in the
more severe patients.
Our finding that hospital-acquired infection is a risk factor for
muscle wasting is novel, but is consistent with present under-
standing regarding the aetiology of muscle wasting in critical ill-
ness, where inflammation is believed to be a major driver.9,22
This is a potentially modifiable risk factor and may be especially
important in resource-limited settings where the incidence of
hospital-acquired infection is particularly high, adding further
justification for improved infection control and preventative
measures.29,30
In addition to those already discussed above, our study has
several additional limitations. Use of the SF-36 in outcome
measurement is limited by its construction and validation
largely in Western populations, thus it may not be sensitive to
cultural effects in our setting. While patients >70 y of age
experienced worse outcomes than younger individuals, a lack of
Vietnamese normative data precludes comparison with the
wider population and our cohort may have normal values for
their age group.
In risk factor evaluation, limited data were available on pre-
existing treatment. While no patients were treated with steroids
during their ICU stay or reported routine use beforehand, ster-
oids can be components of traditional remedies and it is
unknown how many may have been taking these prior to
admission.
We have not carried out health-economic evaluations in this
study. As the majority of our patients were working-age men,
the loss of household income may have serious consequences
for patients, families and local communities. A lack of rehabilita-
tion facilities and no community follow-up services means that
the burden of care is likely to remain with family members
Table 2. Risk factors for muscle wasting from linear mixed effects model. The model was adjusted by time in a non-linear pattern (boundary
knots not shown)
Risk factors Coefficient* 95% CI p-Value
Tetanus Severity Score 0.01 −0.10 to −0.12 0.90
Comorbidity 0.49 −0.67 to −1.64 0.42
Diabetes −0.19 −1.70 to −1.36 0.81
(Age 17)/5 −0.44 −0.60 to −0.28 <0.01
Hospital-acquired infection −0.48 −0.81 to −0.15 <0.01
Mechanical ventilation 0.16 −0.45 to 0.79 0.61
Pipecuronium −0.43 −1.14 to 0.26 0.23
Magnesium sulphate 0.04 −0.46 to 0.55 0.66
Tetanus Severity Score predicts risk of adverse outcome from −8 (low risk) to 46 (high risk). Comorbidity, diabetes, hospital-acquired infection
and mechanical ventilation are binary variables. Pipecuronium and magnesium sulphate are total drugs given in milligrams and grams,
respectively.
*Coefficient is the regression coefficient of the linear mixed effects model representing the change in RF-CSA (in cm2) following 1 unit increase
in the variable score. For example, hospital-acquired infection is associated with a 0.48 cm2 decrease in RF-CSA. For age, starting at age 17 y, a
5-y increase in age is associated with a 0.44 cm2 decrease in RF-CSA.
CI: confidence interval.
Figure 1. Median (95% confidence interval) change in RF-CSA (CSA) com-
pared with baseline according to Ablett severity. Ablett grades 1 and 2:
mild disease with spasms not interfering with respiration; Ablett grades
3 and 4: severe disease with spasms interfering with respiration with or
without autonomic nervous system dysfunction.
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following hospital discharge, further compounding the social
and economic impacts of the disease. In designing strategies to
improve functional recovery after tetanus, future work should
also include health-economic assessment and qualitative evalu-
ation to better understand the economic and emotional conse-
quences of ongoing disability following hospital discharge.
In conclusion, we report that patients with tetanus suffer sig-
nificant muscle wasting that is associated with worse functional
outcome. The effect of muscle wasting on the mental health of
survivors warrants further investigation. Costly Western-style
multidisciplinary models of care are unfeasible in our setting and
alternative solutions are required. Innovative approaches to pro-
vide sustainable but short-course training to physiotherapists in
resource-limited ICUs have already been piloted and experience
from these may be of value in designing future interventions in
rehabilitation.31 In addition, hospital-acquired infection is a
potentially modifiable risk factor for muscle wasting in patients
and efforts should continue to reduce the incidence of infection.
Table 3. Functional outcome scores at hospital discharge and 3 and 6 months
Measurement Hospital discharge (n=79) 3 months (n=75) 6 months (n=71)
Clinical Frailty Score,a median (IQR) 3 (2–4.5) – –
Timed Up and Go (s),b median (IQR) 14 (11–20) – –
Barthel Index,c median (IQR) 100 (80–100) 100 (100–100) 100 (100–100)
SF-36d
Physical functioning, median (IQR) 40 (12.5–77.5) 95 (65–100) 100 (85–100)
Role limitation due to physical health, median (IQR) 0 (0–0) 100 (0–100) 100 (100–100)
Role limitation due to emotional problems, median (IQR) 0 (0–0) 100 (0–100) 100 (100–100)
Energy/fatigue, median (IQR) 50 (30–55) 60 (50–100) 95 (80–100)
Emotional well-being, median (IQR) 60 (51–64) 60 (56–96) 100 (80–100)
Social functioning, median (IQR) 25 (25–37.5) 75 (62.5–100) 100 (87.5–100)
Pain, median (IQR) 32.5 (22.5–43.75) 32.5 (22.5–43.75) 100 (92.5–100)
General health, median (IQR) 50 (30–55) 65 (50–72.5) 70 (65–95)
Health change, median (IQR) 25 (12.5–25) 25 (12.5–25) 50 (50–75)
aClinical Frailty Score is a 7-point scale where 7 represents most frail [18].
bTimed Up and Go measures the time in seconds for an individual to stand up from a seated position, walk 3 m, turn around, return and sit
down [16].
cBathel Index indicates the ability to function independently in activities of daily living with a total score of 100, where 100 represents fully
independent [17].
dSF-36 individual domain scores presented on a scale of 0–100, where 100 represents high function [19].
Figure 2. SF-36 scores at hospital discharge (red line) and 3 months (green) and 6 months (blue) after discharge. The figure shows different
domains: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems,
emotional well-being, social functioning, energy/fatigue, general health perceptions and single-item perceived change in health. The left panel shows
scores in those <70 y of age and the right panel shows scores in those ≥70 y of age.
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